A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

NCT07165015 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment
Healthy
Renal Insufficiency
End Stage Renal Disease (ESRD)

Interventions

DRUG: LY3537031

Sponsor

Eli Lilly and Company